Vimentin (EMT Marker Protein) Score Predicts Resistance to Erlotinib and Radiation Therapy for Patients With Stage III Non-small Cell Lung Cancer on a Prospective Phase II Trial

✍ Scribed by Komaki, R.U.; Kim, Y.B.; Wistuba, I.I.; Tang, X.; Meyn, R.; Allen, P.K.; Wei, X.; Lee, J.J.; O'Reilly, M.S.; Hong, W.K.

• Book ID: 122613250
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 80 KB
• Volume: 84
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2012.07.069